Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
85.29 USD | +1.45% | +16.48% | +19.42% |
05-13 | Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing | MT |
05-08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.42% | 1.53B | |
+31.47% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.23% | 239B | |
+10.06% | 210B | |
-7.36% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- LGND Stock
- News Ligand Pharmaceuticals Incorporated
- Ligand Pharmaceuticals Incorporated : Roth Capital Adjusts Price Target on Ligand Pharmaceuticals to $200 From $195, Maintains Buy Rating